PharVision Advisers’s Oxford Industries OXM Stock Holding History

PharVision Advisers’s Portfolio OXM Stock Details OXM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,331	Closed	-$216K	–	920
2025 Q3	$216K	Buy	+5,331	New	+$231K	0.12%	449

Other funds holding OXM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

PharVision Advisers's OXM Position: Q4 2025 in Review

PharVision Advisers sold out of Oxford Industries (OXM) in Q4 2025, closing a stake of 5,331 shares — an estimated $216K sold.

PharVision Advisers first reported a position in OXM in Q3 2025 and held it in 1 quarter. The position peaked at $216K in Q3 2025. 190 funds tracked by Wall St. Rank hold OXM as of Q4 2025.

PharVision Advisers reported no remaining Oxford Industries position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 5,331 Oxford Industries shares in Q4 2025, an estimated $216K.
PharVision Advisers first reported a position in Oxford Industries in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Oxford Industries position peaked at $216K in Q3 2025.
190 funds tracked by Wall St. Rank held Oxford Industries as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.